Non-Viral Delivery System and Targeted Bone Disease Therapy

IJMS, Vol. 20, Pages 565: Non-Viral Delivery System and Targeted Bone Disease Therapy:

IJMS, Vol. 20, Pages 565: Non-Viral Delivery System and Targeted Bone Disease Therapy

International Journal of Molecular Sciences doi: 10.3390/ijms20030565

Authors:
Abdul Qadir
Yongguang Gao
Patil Suryaji
Ye Tian
Xiao Lin
Kai Dang
Shanfeng Jiang
Yu Li
Zhiping Miao
Airong Qian


Skeletal systems provide support, movement, and protection to the human body. It can be affected by several life suffering bone disorders such as osteoporosis, osteoarthritis, and bone cancers. It is not an easy job to treat bone disorders because of avascular cartilage regions. Treatment with non-specific drug delivery must utilize high doses of systemic administration, which may result in toxicities in non-skeletal tissues and low therapeutic efficacy. Therefore, in order to overcome such limitations, developments in targeted delivery systems are urgently needed. Although the idea of a general targeted delivery system using bone targeting moieties like bisphosphonates, tetracycline, and calcium phosphates emerged a few decades ago, identification of carrier systems like viral and non-viral vectors is a recent approach. Viral vectors have high transfection efficiency but are limited by inducing immunogenicity and oncogenicity. Although non-viral vectors possess low transfection efficiency they are comparatively safe. A number of non-viral vectors including cationic lipids, cationic polymers, and cationic peptides have been developed and used for targeted delivery of DNA, RNA, and drugs to bone tissues or cells with successful consequences. Here we mainly discuss such various non-viral delivery systems with respect to their mechanisms and applications in the specific targeting of bone tissues or cells. Moreover, we discuss possible therapeutic agents that can be delivered against various bone related disorders.